We are delighted to announce that Injective is integrating with Harmony to launch a diverse array of interoperable derivatives. We at Injective have always strived towards the mission of enabling

As a major development in our strategic partnership with Band Protocol, we will now be operating validator nodes on one another’s networks. Moving forward, this dual validator arrangement will

Litentry is integrating with Injective to unlock optimized on-chain data. The process will entail aggregating decentralized identity (DID) data sets across multiple networks. The objective is to optimize services so

Injective and Persistence are joining forces to unlock new opportunities in DeFi. If you’ve been following the rollout of our robust genesis validator network, you may be aware that

Injective Protocol is partnering with Big Data Protocol (BDP) to create and launch structured data token products. Injective and BDP users can soon create and trade data derivatives based on

We are excited to introduce the first ever decentralized synthetic stock future lending products alongside our latest partner EasyFi. Now, users of Injective can take part in innovative lending and

Injective is partnering with KardiaChain to expand our cross-chain trading universe. KardiaChain is a blockchain platform that aims to be fully interoperable and “non-invasive,” meaning that blockchains can connect to

Injective is joining forces with Cartesi to enable mainstream developer adoption of the Injective Chain. Both companies will study together how to integrate Cartesi’s tools on the Injective ecosystem.

We are delighted to announce that Injective has developed a strategic partnership with Tidal Finance to provide insurance for decentralized derivatives. Injective will bring Tidal’s insurance coverage to assets

Injective is partnering with PARSIQ to enable fully automated decentralized trading. This will allow our users to set custom rules that automatically execute trades and other functions based on predefined